Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus.
Parodis I, Sjöwall C, Jönsen A, Ramsköld D, Zickert A, Frodlund M, Sohrabian A, Arnaud L, Rönnelid J, Malmström V, Bengtsson AA, Gunnarsson I.
Parodis I, et al. Among authors: ronnelid j.
Autoimmun Rev. 2017 Apr;16(4):343-351. doi: 10.1016/j.autrev.2017.02.005. Epub 2017 Feb 13.
Autoimmun Rev. 2017.
PMID: 28216072
Review.